Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
fremanezumab
fulcrum therapeutics
gene therapy
generic drugs
What
drug
2
×
remains
2
×
abortion
approval
banned
battleground
bio
biogen’s
biopharmaceutical
block
case
challenging
cnet
companies
convo
earlier
failures
fda
judge
lawsuits
littered
market
medication
mifepristone
nash
new
news
pile
post
price
questions
regulation
road
roe
roundup
strategy
talk
texas
time
Language
unset
Current search:
remains
×
drug
×
@cnet.com
1 year ago
Medication Abortion Remains a Battleground, This Time Challenging US Drug Market - CNET
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
